|
The Biomarker Market
Augurex’s lead biomarker is in the area of arthritis where there is a significant
unmet need for a blood test that provides evidence of structural damage in the joint. Early detection of
joint damage in arthritis is important so that physicians can intervene with suitable therapies that may
change the course of the disease.
|
